惠譽確認旭輝控股(00884.HK)「BB」評級 移除標準觀察名單
評級機構惠譽發表報告,確認旭輝控股(00884.HK)長期外幣和本幣發行人違約評級爲「BB」級別,展望「穩定」,並從標準觀察名單中移除。
報告指出,目前旭輝的業務和財務狀況與其「BB」信貸評級相稱。惠譽認爲,儘管旭輝的槓桿率爲50%,高於同業水平的40%至45%,但旭輝擁有高於行業平均水平的財務靈活性,因而支撐其信貸評級。
旭輝主席林中表示,對惠譽確認評級表示歡迎,證明旭輝的業務發展及財務實力繼續得到資本市場的肯定。管理層通過靈活調撥資金,積極主動管理債務結構及組合,致力提升抵禦行業及週期風險的能力,保持集團的財務健康及長期可持續發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.